Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mohammad Sahraian and Abdorreza Naser Moghadasi.
Mohammad Sahraian
Connection Strength
8.840
Abdorreza Naser Moghadasi
  1. Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis. Mult Scler Relat Disord. 2020 Nov; 46:102472.
    View in: PubMed
    Score: 0.900
  2. Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic. Arch Iran Med. 2020 07 01; 23(7):509-510.
    View in: PubMed
    Score: 0.890
  3. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran. Mult Scler Relat Disord. 2020 09; 44:102245.
    View in: PubMed
    Score: 0.885
  4. Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran. Mult Scler Relat Disord. 2020 07; 42:102193.
    View in: PubMed
    Score: 0.882
  5. Therapeutic Use of Intrathecal Mesenchymal Stem Cells in patients with Multiple Sclerosis: A Pilot Study with Booster Injection. Immunol Invest. 2019 Feb; 48(2):160-168.
    View in: PubMed
    Score: 0.783
  6. Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis. Eur Neurol. 2017; 77(5-6):258-261.
    View in: PubMed
    Score: 0.710
  7. Progressive solitary sclerosis presented with diplopia: A case report. Mult Scler Relat Disord. 2019 Feb; 28:129-131.
    View in: PubMed
    Score: 0.400
  8. The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran. Mult Scler Relat Disord. 2018 10; 25:143.
    View in: PubMed
    Score: 0.389
  9. Anti-JC virus antibody sera positivity and index value among patients with multiple sclerosis may be correlated with age, sex, and area of residence. J Neurovirol. 2018 10; 24(5):570-576.
    View in: PubMed
    Score: 0.384
  10. Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study. Iran J Neurol. 2018 Apr 04; 17(2):64-70.
    View in: PubMed
    Score: 0.381
  11. Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients. Mult Scler Relat Disord. 2020 06; 41:102164.
    View in: PubMed
    Score: 0.220
  12. Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms. Basic Clin Neurosci. 2020 Mar-Apr; 11(2):201-206.
    View in: PubMed
    Score: 0.219
  13. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review. Mult Scler Relat Disord. 2019 Jan; 27:350-363.
    View in: PubMed
    Score: 0.199
  14. Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study. Acta Neurol Belg. 2018 Jun; 118(2):277-287.
    View in: PubMed
    Score: 0.189
  15. A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review. Mult Scler Relat Disord. 2018 May; 22:22-26.
    View in: PubMed
    Score: 0.189
  16. Neuromyelitis optica spectrum disorders in Iran. Mult Scler Relat Disord. 2017 Nov; 18:209-212.
    View in: PubMed
    Score: 0.184
  17. Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Mult Scler Relat Disord. 2017 Nov; 18:144-151.
    View in: PubMed
    Score: 0.184
  18. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study. Mult Scler Relat Disord. 2017 Feb; 12:39-43.
    View in: PubMed
    Score: 0.175
  19. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci. 2021 Aug; 42(8):3093-3099.
    View in: PubMed
    Score: 0.119
  20. Pain in Patients with Multiple Sclerosis. Maedica (Bucur). 2018 Jun; 13(2):125-130.
    View in: PubMed
    Score: 0.096
  21. Evaluating the relationship between emotional intelligence and cognitive disorders in patients with Multiple Sclerosis. Iran J Neurol. 2018 Apr 04; 17(2):78-81.
    View in: PubMed
    Score: 0.095
  22. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment. J Neurol Sci. 2018 05 15; 388:222-231.
    View in: PubMed
    Score: 0.094
  23. Recurrent isolated optic neuritis: A study on 22 patients. Iran J Neurol. 2017 Jul 06; 16(3):130-135.
    View in: PubMed
    Score: 0.090
  24. The first attack of multiple sclerosis presented immediately after voluntary and intensive weight loss: A case series. Iran J Neurol. 2017 Jan 05; 16(1):41-42.
    View in: PubMed
    Score: 0.087
  25. Disability and Therapeutic Response in Paediatric Neuromyelitis Optica Spectrum Disorder: A Case Series from Iran. Iran J Child Neurol. 2019; 13(3):99-104.
    View in: PubMed
    Score: 0.050
  26. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children. Iran J Child Neurol. 2017; 11(2):37-43.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.